pneumococcal 13-valent conjugate vaccine

CHEBI:CHEBI_751802

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
route
INTRAMUSCULAR
dosage_form
INJECTION, SUSPENSION
product_type
VACCINE
marketing_category
BLA
pharm_class
Conjugate [CS]
active_ingredient_name
STREPTOCOCCUS PNEUMONIAE TYPE 9V CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN
marketing_start_date
20100312
package_marketing_start_date
20100312
labeler_name
A-S Medication Solutions
generic_name
pneumococcal 13-valent conjugate vaccine
brand_name
PREVNAR 13
brand_name_base
PREVNAR 13
product_ndc
50090-1944
application_number
BLA125324
spl_id
e7d82789-54b1-4a5b-b9bf-982616a93ec6
active_ingredient_strength
4.4 ug/.5mL
package_ndc
50090-1944-1
package_description
1 SYRINGE in 1 POUCH (50090-1944-1) / .5 mL in 1 SYRINGE (50090-1944-0)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class